SAFIRA­®

About SAFIRA

SAFIRA®: SAFer Injection for Regional Anaesthesia

• Creates a single operator procedure
• Engineered safety solution to control injection pressure threshold
• Reduces chances of nerve injury
• Improves patient safety

Current Regional Anaesthesia process:

Current regional anaesthesia procedures require two operators - an anaesthetist who holds an ultrasound scanner and uses this to guide the needle tip placement and a second operator to inject the anaesthetic solution at a required pressure.

It has been reported that anaesthetic solutions are often injected at high pressure.

High pressure can cause damage to nerve fascicles, with serious nerve damage occurring in up to 1% of procedures and transient nerve damage in up to 8% of cases.

A revolutionary new technology for Regional Anaesthesia:

SAFIRA® - SAFer Injection for Regional Anaesthesia - allows a single operator, an anaesthetist or anesthesiologist, to conduct the whole regional block at safer pressures.

SAFIRA® has been developed in line with international quality standards. Medovate is ISO 13485:2016 certified.

Contact Distributors:

Medovate have appointed distributors for this exciting new technology in the United States of America, Australia and New Zealand, and Israel.

Find details of all appointed distributors here.

Distributors for other countries are in the process of being appointed.

Videos about SAFIRA®:

Scroll down to find and watch videos all about the new SAFIRA® technology.